PACB launched SPRQ-Nx and multi-use SMRT Cells for Revio, lowering sequencing costs by about 30%. PacBio says SPRQ-Nx can push human genome sequencing costs below $300 at scale. PACB upgraded ...
Over the past two decades, high‑throughput sequencing has dramatically expanded our understanding of the gut microbiome's composition.
The gut microbiome is not a mere spectator but an active player in colorectal cancer (CRC), driving tumor initiation and ...
On May 26, Pacific Biosciences of California, Inc. (NASDAQ:PACB) began global shipments of its SPRQ-Nx sequencing chemistry ...
PacBio PACB recently announced the worldwide commercial availability of its SPRQ-Nx sequencing chemistry and new multi-use SMRT Cells for the Revio HiFi sequencing platform. The launch is expected to ...
Burkitt lymphoma carries multiple oncogenic drivers yet arises predominantly in children, whose normal cells harbour few age-related mutations. To investigate this paradox, we seek to define the ...
Single-cell RNA sequencing enables high-resolution analysis of cellular heterogeneity, yet disentangling biological signal from batch effects remains challenging. Existing batch-correction algorithms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results